Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $72.9 million.

  • Prestige Consumer Healthcare's Accumulated Expenses rose 1967.5% to $72.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $72.9 million, marking a year-over-year increase of 1967.5%. This contributed to the annual value of $63.5 million for FY2025, which is 1300.71% up from last year.
  • Prestige Consumer Healthcare's Accumulated Expenses amounted to $72.9 million in Q4 2025, which was up 1967.5% from $68.5 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's 5-year Accumulated Expenses high stood at $78.6 million for Q3 2021, and its period low was $54.9 million during Q2 2024.
  • For the 5-year period, Prestige Consumer Healthcare's Accumulated Expenses averaged around $66.4 million, with its median value being $66.7 million (2021).
  • Per our database at Business Quant, Prestige Consumer Healthcare's Accumulated Expenses skyrocketed by 2077.15% in 2021 and then crashed by 2257.18% in 2024.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Accumulated Expenses stood at $71.0 million in 2021, then fell by 0.01% to $71.0 million in 2022, then fell by 8.34% to $65.1 million in 2023, then dropped by 6.38% to $60.9 million in 2024, then grew by 19.67% to $72.9 million in 2025.
  • Its Accumulated Expenses stands at $72.9 million for Q4 2025, versus $68.5 million for Q3 2025 and $63.8 million for Q2 2025.